These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34878871)

  • 1. Comparing the COVID-19 Responses in Cuba and the United States.
    Powell MA; Erwin PC; Bermejo PM
    Am J Public Health; 2021 Dec; 111(12):2186-2193. PubMed ID: 34878871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cuba's COVID-19 Strategy: Main Actions through April 23, 2020.
    MEDICC Rev; 2020 Apr; 22(2):50-52. PubMed ID: 33295309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Requires Innovation, Regulation and Rigor: Amaylid Arteaga-García MD MS Director, National Clinical Trials Coordinating Center (CENCEC).
    Aguilar TL; Gorry C
    MEDICC Rev; 2021 Apr; 23(2):9. PubMed ID: 33974607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines and Public Trust: Containing COVID-19 in Cuba.
    Gorry C
    MEDICC Rev; 2022 Jan; 24(1):9-13. PubMed ID: 35157633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess Death Rates by State During the COVID-19 Pandemic: United States, 2020‒2023.
    Woolf SH; Lee JH; Chapman DA; Sabo RT; Zimmerman E
    Am J Public Health; 2024 Sep; 114(9):882-891. PubMed ID: 39024530
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal Antibodies vs COVID-19: Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center.
    Aguilar TL; Gorry C
    MEDICC Rev; 2021 Apr; 23(2):12. PubMed ID: 33974610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of COVID-19 responses in South Korea and the United States.
    Choi O; Kim S
    Glob Health Action; 2024 Dec; 17(1):2370611. PubMed ID: 39135484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Bollyky TJ; Castro E; Aravkin AY; Bhangdia K; Dalos J; Hulland EN; Kiernan S; Lastuka A; McHugh TA; Ostroff SM; Zheng P; Chaudhry HT; Ruggiero E; Turilli I; Adolph C; Amlag JO; Bang-Jensen B; Barber RM; Carter A; Chang C; Cogen RM; Collins JK; Dai X; Dangel WJ; Dapper C; Deen A; Eastus A; Erickson M; Fedosseeva T; Flaxman AD; Fullman N; Giles JR; Guo G; Hay SI; He J; Helak M; Huntley BM; Iannucci VC; Kinzel KE; LeGrand KE; Magistro B; Mokdad AH; Nassereldine H; Ozten Y; Pasovic M; Pigott DM; Reiner RC; Reinke G; Schumacher AE; Serieux E; Spurlock EE; Troeger CE; Vo AT; Vos T; Walcott R; Yazdani S; Murray CJL; Dieleman JL
    Lancet; 2023 Apr; 401(10385):1341-1360. PubMed ID: 36966780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUBA'S COVID-19 STRATEGY: UPDATED EPIDEMIC CONTROL AND RECOVERY MEASURES.
    MEDICC Rev; 2020 Jul; 22(3):5. PubMed ID: 32812892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Paltiel AD; Zheng A; Schwartz JL
    Ann Intern Med; 2021 Apr; 174(4):568-570. PubMed ID: 33395345
    [No Abstract]   [Full Text] [Related]  

  • 11. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.
    Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuba's National Regulatory Authority & COVID-19: Olga Lidia Jacobo-Casanueva MS Director, Center for State Control of Medicines and Medical Devices (CECMED).
    Aguilar-Guerra TL; Fajardo-Díaz EM; Gorry C
    MEDICC Rev; 2021; 23(3-4):9-14. PubMed ID: 34516531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study.
    Post LA; Issa TZ; Boctor MJ; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Faber JMM; Culler K; Brandt CA; Oehmke JF
    J Med Internet Res; 2020 Dec; 22(12):e24286. PubMed ID: 33216726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOBERANA, Cuba's COVID-19 Vaccine Candidates: Dagmar García-Rivera PhD.
    Gorry C
    MEDICC Rev; 2020 Oct; 22(4):10-15. PubMed ID: 33295312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Surveillance Needed to Contain COVID-19.
    Shrivastava SR; Shrivastava PS
    MEDICC Rev; 2021 Jan; 23(1):92. PubMed ID: 33780430
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 in Cuba: Assessing the National Response.
    Galbán-García E; Más-Bermejo P
    MEDICC Rev; 2020 Oct; 22(4):29-34. PubMed ID: 33295317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rapid Survey of State and Territorial Public Health Partnerships With Faith-Based Organizations to Promote COVID-19 Vaccination.
    Santibañez S; Ottewell A; Harper-Hardy P; Ryan E; Christensen H; Smith N
    Am J Public Health; 2022 Mar; 112(3):397-400. PubMed ID: 35196042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: Reflections.
    James JJ
    Disaster Med Public Health Prep; 2020 Dec; 14(6):e8-e11. PubMed ID: 32498744
    [No Abstract]   [Full Text] [Related]  

  • 20. Full Technical Report: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba.
    Osterholm MT; Rabadán-Diehl C; Anzinger J; Bottazzi ME; Christie-Samuels C; Erondu N; Marrazzo J; Milan S; Quashie PK; Schwaab T; Williams D
    MEDICC Rev; 2022 Oct; 24(3-4):72-108. PubMed ID: 36417340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.